Diabetes mellitus is a highly prevalent comorbidity in patients participating in cardiopulmonary rehabilitation. However, specific guidelines and recommendations for the management of diabetes in this setting are very limited. Recommendations about glycemic targets, as well as the management of glycemic variability, which can have significant impacts on morbidity and mortality, are not clear. The utilization of continuous glucose monitoring (CGM) has the potential to optimize glycemic variability and inform treatment decisions in patients with diabetes undergoing cardiopulmonary rehabilitation, however, outside of diabetes specialists, other clinicians that care for these patients may not be aware of the utility of CGM in this setting.
Presented by: Anne K. Peters, MD
Disclosures:
Grant/Research Support:
Dexcom, vTv Therapeutics
Consultant (Participation on an advisory board for): Abbott Diabetes Care, Bigfoot, Boehringer Ingelheim, Eli Lilly and Company, Lexicon, Livongo, MannKind, Medscape, Merck, Novo Nordisk, Sanofi
Diabetes mellitus is a highly prevalent comorbidity in patients participating in cardiopulmonary rehabilitation. However, specific guidelines and recommendations for the management of diabetes in this setting are very limited. Recommendations about glycemic targets, as well as the management of glycemic variability, which can have significant impacts on morbidity and mortality, are not clear. The utilization of continuous glucose monitoring (CGM) has the potential to optimize glycemic variability and inform treatment decisions in patients with diabetes undergoing cardiopulmonary rehabilitation, however, outside of diabetes specialists, other clinicians that care for these patients may not be aware of the utility of CGM in this setting.
Learning Objectives:
- Discuss diabetes outcomes beyond HbA1c, particularly with regards to cardiovascular risk reduction
- Consider how CGM technology can help improve these outcomes, as well as optimize exercise and nutritional regimens
- Review CGM devices and develop a clinical strategy for their use in patients with diabetes participating in cardiopulmonary rehabilitation
Viewing Window: 60 days from date of purchase
| Title | Credit(s) | |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| 4 |